Showing results (251-260 of 423) with videos related to

Sort By:
Pageof 43
Journal of Hypertension|February 8, 2017
Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trialsEmily R Atkins, Yoichiro Hirakawa, Abdul Salam, et al.
The Lancet. Diabetes & Endocrinology|September 10, 2019
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysisBrendon L Neuen, Tamara Young, Hiddo J L Heerspink, et al.
BMC Nephrology|July 14, 2019
Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis studyZhipeng Zhan, Brendan Smyth, Nigel D Toussaint, et al.
European Journal of Heart Failure|June 27, 2024
Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trialMuthiah Vaduganathan, Christopher P Cannon, Meg J Jardine, et al.
Diabetologia|August 20, 2021
Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trialTaha Sen, Jingwei Li, Brendon L Neuen, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 29, 2018
Dietary Sodium Reduction Reduces Albuminuria: A Cluster Randomized TrialMeg J Jardine, Nicole Li, Toshiharu Ninomiya, et al.
Circulation|August 21, 2023
Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE TrialJames L Januzzi, Reza Mohebi, Yuxi Liu, et al.
Anesthesiology|February 5, 2013
Preoperative estimates of glomerular filtration rate as predictors of outcome after surgery: a systematic review and meta-analysisJohn F Mooney, Isuru Ranasinghe, Clara K Chow, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 4, 2025
Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: Insights from the CREDENCE trialBryony Beal, Luke Buizen, Emily K Yeung, et al.
Journal of Hypertension|October 1, 2010
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trialsSébastien Czernichow, Alberto Zanchetti, Fiona Turnbull, et al.
Pageof 43